Canada Pension Plan Investment Board’s AstraZeneca AZN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$253M Buy
1,347,313
+685,768
+104% +$129M 0.14% 149
2026
Q1
$129M Buy
+661,545
New +$128M 0.08% 220
2019
Q3
– Sell
-296,300
Closed -$24.5M – 1191
2019
Q2
$24.5M Hold
296,300
– – 0.05% 301
2019
Q1
$24M Sell
296,300
-358,500
-55% -$28.3M 0.05% 340
2018
Q4
$49.7M Sell
654,800
-403,900
-38% -$31.5M 0.11% 149
2018
Q3
$83.8M Hold
1,058,700
– – 0.15% 114
2018
Q2
$74.3M Sell
1,058,700
-94,100
-8% -$6.77M 0.14% 129
2018
Q1
$80.6M Buy
1,152,800
+510,600
+80% +$35.4M 0.14% 141
2017
Q4
$44.6M Buy
642,200
+567,949
+765% +$38.3M 0.08% 213
2017
Q3
$5.03M Buy
74,251
+74,201
+148,402% +$4.69M 0.01% 662
2017
Q2
$3K Sell
50
-885,600
-100% -$57.8M ﹤0.01% 1091
2017
Q1
$55.2M Hold
885,650
– – 0.14% 115
2016
Q4
$48.4M Hold
885,650
– – 0.18% 94
2016
Q3
$58.2M Buy
885,650
+453,250
+105% +$29.6M 0.21% 93
2016
Q2
$26.1M Buy
+432,400
New +$25.1M 0.11% 159
2015
Q1
– Sell
-50,000
Closed -$3.52M – 1131
2014
Q4
$3.52M Buy
+50,000
New +$3.58M 0.01% 677
2013
Q4
– Sell
-10,146
Closed -$527K – 1230
2013
Q3
$527K Hold
10,146
– – ﹤0.01% 777
2013
Q2
$480K Buy
+10,146
New +$517K ﹤0.01% 683

Other funds holding AZN

Canada Pension Plan Investment Board's AZN Position: Q2 2026 in Review

Canada Pension Plan Investment Board increased its AstraZeneca (AZN) stake by 104% in Q2 2026, buying an estimated $129M and bringing the position to 1,347,313 shares worth $253M. The position accounts for 0.14% of the portfolio, ranked #149.

Canada Pension Plan Investment Board first reported a position in AZN in Q2 2013 and has held it in 18 quarters since. 1,507 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • Canada Pension Plan Investment Board held 1,347,313 shares of AstraZeneca worth $253M as of Q2 2026.
  • Canada Pension Plan Investment Board bought 685,768 AstraZeneca shares in Q2 2026, an estimated $129M.
  • AstraZeneca made up 0.14% of Canada Pension Plan Investment Board's portfolio in Q2 2026, its #149 holding.
  • Canada Pension Plan Investment Board first reported a position in AstraZeneca in Q2 2013 and has held it in 18 quarters since.
  • 1,507 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Canada Pension Plan Investment Board's 13F filing for Q2 2026, filed 14 Aug 2026.